ORTHO OPTIX™ Reader Completes Transfusion Medicine Portfolio, Now Available in Canada
When paired with the ORTHO™ Workstation, the ORTHO OPTIX Reader provides a complete semi-automated testing platform for transfusion labs with low- to mid-volume throughput. The ORTHO OPTIX Reader has been shown to deliver 99.9% concordance1, demonstrated by the award-winning fully automated ORTHO VISION® Analyzer. The concordant and high-resolution images of the ORTHO OPTIX Reader help to support the technologist during remote review of results from across the laboratory. It also offers larger volume labs and health care networks a way to back-up or scale up their operations without having to invest in an additional full-automation analyzer.
"We're pleased to announce the launch of the ORTHO OPTIX Reader in
The ORTHO OPTIX Reader's high-resolution camera captures color, grayscale, front and back images of each test without operator intervention, which provides objective data for automated results interpretation and eliminates the subjectivity and discrepancies associated with human reading of results.
The ORTHO OPTIX Reader leverages the same proven ORTHO ID-MTS™ Gel card Technology as the ORTHO VISION Analyzer and a comprehensive testing menu.
When connected to the customer's laboratory information system, column grades and images can be automatically sent for long-term retention of result interpretations, therefore reducing and/or eliminating the need for manual documentation of results. The system audit log and reporting module enhances traceability and reporting capabilities to keep labs compliant with accreditations and regulations. It also utilizes best-in-class ID-MTS™ Gel Card technology which offers a comprehensive testing menu to help standardize lab practices.
The ORTHO OPTIX Reader is now available in
More than 800,000 patients across the world are impacted by Ortho's tests each day. Because Every Test is a LifeTM, Ortho provides hospitals, hospital networks, clinical laboratories and blood banks around the world with innovative technology to ensure test results are fast, accurate, and reliable. Ortho's customized solutions enhance clinical outcomes, improve efficiency, overcome lab staffing challenges and reduce costs.
From launching the first product to determine Rh+ or Rh- blood type, developing the world's first tests for the detection of antibodies against HIV and hepatitis C, introducing patented dry-slide technology and marketing the first
The company is powered by
1 For direct and indirect antiglobulin testing, as determined by External Validation Testing using ID-MTSTM Gel Card Technology. The acceptance criteria for concordance for direct and indirect antiglobulin was ≥98.0% with a lower bound 95% CI of 99.87%.
View original content to download multimedia:https://www.prnewswire.com/news-releases/ortho-optix-reader-completes-transfusion-medicine-portfolio-now-available-in-canada-301340389.html
Ortho Media Relations, firstname.lastname@example.org